FDA Investigation Unlikely to Influence Biogen's (BIIB) Aduhelm Uptake - Analyst
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- US stocks close down as oil spikes 12%, job market weakens
- U.S. nonfarm payroll employment unexpectedly falls in February
- Oracle stock falls on report of scrapped Texas data center plans
- Kuwait cuts oil output as storage fills up
- Boeing reportedly nearing 500-aircraft deal with China ahead of Trump visit
- After-hours movers: Marvell, Samsara, GAP, Cooper Cos.
- After-hours movers: Broadcom, StubHub, Cracker Barrel, Grocery Outlet, Veeva Systems and more
- After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
- After-hours movers: MongoDB, Credo, SoFi Technologies and more
- After-hours movers: Dell, Block, CoreWeave, Autodesk, MARA and more
FDA seeks probe into its talks with Biogen before Alzheimer's drug approval
July 9, 2021 2:37 PM UTCBy Manas Mishra
(Reuters) - The U.S. Food and Drug Administration on Friday called for an independent federal probe into its representatives' interactions with Biogen Inc that led to approval of the company's Alzheimer's disease drug last month.
The drugmaker's shares closed down 3% after the agency's acting commissioner Janet Woodcock asked the Office of the Inspector General at the Department of Health and Human Services to probe if the talks were inconsistent with the regulator's policies.
"We received the letter and are reviewing it for appropriate action," Tesia Williams, a spokesperson of HHS's Office of the... More
Biogen (BIIB) Shares Down 4% As Head of FDA Calls for a Federal Investigation into Approval of Aduhelm
July 9, 2021 1:36 PM UTCBiogen (NASDAQ: BIIB) shares are trading 4% lower following a call by the head of the FDA to investigate the infamous Alzheimers drugs approval process.
In an open letter posted on Twitter on Friday, Dr. Janet Woodstock, Acting Commissioner of the FDA,... More
FDA calls for federal investigation into its controversial Alzheimer's drug approval - STAT
July 9, 2021 12:53 PM UTCFDA calls for federal investigation into its controversial Alzheimers drug approval - STAT
Related Stock:
Biogen (NASDAQ: BIIB)
... More